<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03755817</url>
  </required_header>
  <id_info>
    <org_study_id>2017015F</org_study_id>
    <nct_id>NCT03755817</nct_id>
  </id_info>
  <brief_title>Efficacy Assessment of SCENAR Device on Common Spinal Pain Syndrome</brief_title>
  <acronym>SCENAR1</acronym>
  <official_title>Immediate Efficacy Assessment of SCENAR's Session on a Common Spinal Pain Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, singled blinded, controlled trial of the efficacy of a SCENAR session in patients
      with vertebral pain. SCENAR is an electrotherapy device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy on resting pain at the end of SCENAR application: NRS</measure>
    <time_frame>30 minutes</time_frame>
    <description>Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy on pain at mobilization the end of SCENAR application: NRS</measure>
    <time_frame>30 minutes</time_frame>
    <description>Self-assessment of pain intensity using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on anxiety the end of SCENAR application: NRS</measure>
    <time_frame>30 minutes</time_frame>
    <description>Self-assessment of anxiety using the pain numeric rating scale (NRS), on which patients rate their current anxiety from 0 (&quot;no anxiety&quot;) to 10 (&quot;worst possible anxiety&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on the sensation of spinal blockage at the end of SCENAR application: NRS</measure>
    <time_frame>30 minutes</time_frame>
    <description>Self-assessment of the sensation of spinal blockage using the numeric rating scale (NRS), on which patients rate their current blockage from 0 (&quot;complete blockage&quot;) to 10 (&quot;perfect mobility&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on resting pain on the following day: NRS</measure>
    <time_frame>1 day</time_frame>
    <description>Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on pain at mobilization on the following day: NRS</measure>
    <time_frame>1 day</time_frame>
    <description>Self-assessment of pain using the pain numeric rating scale (NRS), on which patients rate their current pain intensity from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on the sensation of spinal blockage on the following day: NRS</measure>
    <time_frame>1 day</time_frame>
    <description>Self-assessment of the sensation of spinal blockage using the numeric rating scale (NRS), on which patients rate their current anxiety from 0 (&quot;complete blockage&quot;) to 10 (&quot;perfect mobility&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy on anxiety on the following day: NRS</measure>
    <time_frame>1 day</time_frame>
    <description>Self-assessment of anxiety using the numeric rating scale (NRS), on which patients rate their current anxiety from 0 (&quot;no anxiety&quot;) to 10 (&quot;worst possible anxiety&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collection of possible side effects</measure>
    <time_frame>1 day</time_frame>
    <description>Open question</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>Scenar application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Application of SCENAR device on</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scenar application with the device off</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Application of SCENAR device off</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SCENAR application</intervention_name>
    <description>Active SCENAR application on the painful area</description>
    <arm_group_label>Scenar application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SCENAR application with the device off</intervention_name>
    <description>Placebo SCENAR application on the painful area</description>
    <arm_group_label>Scenar application with the device off</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female over 18 and under 80 years of age

          -  Suffering of common spinal pain: cervical pain including cervico-brachial neuralgia,
             lumbar pain including lumbo-radiculalgia

          -  Having attended a &quot;pain consultation&quot; or referred to a pain consultant during
             hospitalization

          -  Having signed the consent form

          -  Can be contacted directly by phone if patient is not hospitalized

          -  Be affiliated to a national insurance scheme or benefiting from such a program

        Non-inclusion Criteria:

          -  Pregnant or breast-feeding women

          -  Patients with a pacemaker

          -  Patients whose skin condition makes the use of SCENAR impossible (wounds, recent
             scars, skin infections)

          -  Patient whose spinal pain is known to be related to inflammatory pathology
             (spondylarthropathy, rheumatoid arthritis, chondrocalcinosis), trauma (fractures and
             dislocations), tumor (metastases, myeloma localization), spondylodiscitis infectious,
             neurological (intrarachidian tumor or posterior fossa) or radiculalgia with deficient
             signs

          -  Patients who have already had a SCENAR session

          -  Patients who have already participated in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Fischler, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hopital Foch</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisabeth Hulier-Ammar</last_name>
    <phone>+33146251175</phone>
    <email>drci-promotion@hopital-foch.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>HÃ´pital Foch</name>
      <address>
        <city>Suresnes</city>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Fischler, MD PhD</last_name>
      <phone>+33146252442</phone>
      <email>m.fischler@hopital-foch.org</email>
    </contact>
    <investigator>
      <last_name>Mireille Michel-Cherqui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 26, 2018</study_first_submitted>
  <study_first_submitted_qc>November 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2018</study_first_posted>
  <last_update_submitted>December 31, 2019</last_update_submitted>
  <last_update_submitted_qc>December 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

